{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T21:06:26Z","timestamp":1773349586765,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1995,12,1]],"date-time":"1995-12-01T00:00:00Z","timestamp":817776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Nuerosci"],"published-print":{"date-parts":[[1995,12]]},"DOI":"10.1007\/bf02191808","type":"journal-article","created":{"date-parts":[[2005,9,21]],"date-time":"2005-09-21T10:41:22Z","timestamp":1127299282000},"page":"1-6","source":"Crossref","is-referenced-by-count":20,"title":["Cardiovascular effects of fluvoxamine and maprotiline in depressed patients"],"prefix":"10.1007","volume":"246","author":[{"given":"Walter","family":"Hewer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolf","family":"Rost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wagner F.","family":"Gattaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02191808_CR1","first-page":"460","volume":"45","author":"S Ahles","year":"1984","unstructured":"Ahles S, Gwirtsman H, Halaris A, Shah P, Schwarcz G, Hill MA (1984) Comparative cardiac effects of maprotiline and doxepin in elderly patients. J Clin Psychiatry 45:460\u2013465","journal-title":"J Clin Psychiatry"},{"key":"BF02191808_CR2","first-page":"353","volume":"7","author":"HC Bazett","year":"1920","unstructured":"Bazett HC (1920) Analysis of the time relation of ECG. Heart 7:353","journal-title":"Heart"},{"key":"BF02191808_CR3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/00003495-198632040-00002","volume":"32","author":"P Benfield","year":"1986","unstructured":"Benfield P, Ward A (1986) Fluvoxamine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 32:313\u2013334","journal-title":"Drugs"},{"key":"BF02191808_CR4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00005344-198201000-00023","volume":"4","author":"KP Bethge","year":"1982","unstructured":"Bethge KP, Godt U, Blanco-Cruz E, Lichtlen PR (1982) Incidence of cardiac arrhythmias during antidepressant therapy with maprotiline or nomifensine. J Cardiovasc Pharmacol 4:142\u2013148","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF02191808_CR5","first-page":"15","volume-title":"Side effects of drugs","author":"B Blackwell","year":"1986","unstructured":"Blackwell B (1986) Antidepressant drugs. In: Dukes MNG (ed) Side effects of drugs. Elsevier, Amsterdam, pp 15\u201326"},{"key":"BF02191808_CR6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0167-5273(83)90010-4","volume":"2","author":"D Burckhardt","year":"1983","unstructured":"Burckhardt D (1983) Clinical relevance of cardiovascular side effects of tri-and tetracyclic antidepressants-fear or facts. Int J Cardiol 2:387\u2013389","journal-title":"Int J Cardiol"},{"key":"BF02191808_CR7","doi-asserted-by":"crossref","first-page":"249S","DOI":"10.1111\/j.1365-2125.1983.tb05872.x","volume":"15","author":"JG Edwards","year":"1983","unstructured":"Edwards JG, Goldie A (1983) Minaserin, maprotiline and intracardiac conduction. Br J Clin Pharmacol 15:249S-254S","journal-title":"Br J Clin Pharmacol"},{"key":"BF02191808_CR8","first-page":"385","volume":"51","author":"JM Ellison","year":"1990","unstructured":"Ellison JM, Milofsky JE, Ely E (1990) Fluoxetine-induced bradycardia and syncope in two patients. J Clin Psychiatry 51:385\u2013386","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"BF02191808_CR9","first-page":"42","volume":"46","author":"C Fisch","year":"1985","unstructured":"Fisch C (1985) Effect of Fluoxetine on the electrocardiogram. J Clin Psychiatry 46(3):42\u201344","journal-title":"J Clin Psychiatry"},{"key":"BF02191808_CR10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/clpt.1987.102","volume":"42","author":"EGV Giardina","year":"1987","unstructured":"Giardina EGV, Cooper TB, Suckow R, Saroff AL (1987) Cardiovascular effects of doxepin in cardiac patients with ventricular arrhythmias. Clin Pharmacol Ther 42:20\u201327","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl","key":"BF02191808_CR11","first-page":"16","volume":"54","author":"AH Glassman","year":"1993","unstructured":"Glassman AH, Preud'homme XA (1993) Review of the cardiovascular effects of heterocyclic antidepressants. J Clin Psychiatry 54: 2 (Suppl) 16\u201322","journal-title":"J Clin Psychiatry"},{"key":"BF02191808_CR12","first-page":"1437","volume-title":"Psychopharmacology: the third generation of progress","author":"AH Glassman","year":"1987","unstructured":"Glassman AH, Roose SP, Giardina EGV, Bigger JT (1987) Cardiovascular effects of tricyclic antidepressants. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 1437\u20131442"},{"key":"BF02191808_CR13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF01244999","volume":"93","author":"K Gradin","year":"1993","unstructured":"Gradin K, Persson B (1993) Cardiovascular effects of intrathecal administration of agents active at 5-hydroxytryptamine-receptors in the rat: modulation by substance P and a substance P antagonist. J Neural Transm 93:225\u2013234","journal-title":"J Neural Transm"},{"key":"BF02191808_CR14","first-page":"368","volume":"50","author":"JW Jefferson","year":"1989","unstructured":"Jefferson JW (1989) Cardiovascular effects and toxicity of anxiolytics and antidepressants. J Clin Psychiatry 50:368\u2013378","journal-title":"J Clin Psychiatry"},{"key":"BF02191808_CR15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-2007-1014428","volume":"24","author":"F Jorghe de","year":"1991","unstructured":"Jorghe F de, Swinkels J, Tuynman-Qua H (1991) Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression. Pharmacopsychiatry 24:21\u201327","journal-title":"Pharmacopsychiatry"},{"issue":"Suppl 1","key":"BF02191808_CR16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00002826-199202001-00815","volume":"15","author":"T Kalelioglu","year":"1992","unstructured":"Kalelioglu T, Eradamlar N, Kantara E, Verimli A, Alpkan L, Begazyurek M (1992) Mianserin and maprotiline and their anticholinergic side effects. Clin Neuropharmacol 15 (Suppl 1):419B","journal-title":"Clin Neuropharmacol"},{"key":"BF02191808_CR17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF02244107","volume":"102","author":"H Kuhs","year":"1990","unstructured":"Kuhs H, Rudolf GAE (1990) Cardiovascular effects of paroxetine. Psychopharmacology 102:379\u2013382","journal-title":"Psychopharmacology"},{"key":"BF02191808_CR18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1192\/bjp.148.6.676","volume":"148","author":"SP Kutcher","year":"1986","unstructured":"Kutcher SP, Reid K, Dubbin JD, Shulman KI (1986) Electrocardiogram changes and therapeutic desipramine and 2-hydroxydesipramine concentrations in elderly depressives. Br J Psychiatry 148:676\u2013679","journal-title":"Br J Psychiatry"},{"key":"BF02191808_CR19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0002-8703(82)90281-2","volume":"103","author":"JB Marshall","year":"1982","unstructured":"Marshall JB, Forker AD (1982) Cardiovascular effects of tricyclic antidepressant drugs: therapeutic usage, overdose, and management of complications. Am Heart J 103:401\u2013414","journal-title":"Am Heart J"},{"key":"BF02191808_CR20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0022-3956(89)90019-8","volume":"23","author":"RE McCue","year":"1989","unstructured":"McCue RE, Georgotas A, Nagachandran N, Basir MA, Go EA, Suckow RF, Cooper TB (1989) Plasma levels of nortriptyline and 10-hydroxynortriptyline and treatment-related electrocardiographic changes in the elderly depressed. J Psychiatr Res 23:73\u201379","journal-title":"J Psychiatr Res"},{"key":"BF02191808_CR21","first-page":"738","volume":"25","author":"DH Mielke","year":"1979","unstructured":"Mielke DH, Koepke RP, Phillips JH (1979) A controlled evaluation of a tetracyclic (maprotiline) and a tricyclic (imipramine) antidepressant and their effects on the heart. Curr Ther Res 25:738\u2013742","journal-title":"Curr Ther Res"},{"key":"BF02191808_CR22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2165\/00003495-197713050-00001","volume":"13","author":"RM Pinder","year":"1977","unstructured":"Pinder RM, Brogden RN, Speight TM, Avery GS (1977) Maprotiline: a review of its pharmacological properties and therapeutic efficacy in mental depressive states. Drugs 13:321\u2013352","journal-title":"Drugs"},{"key":"BF02191808_CR23","first-page":"133","volume":"2","author":"G Prager","year":"1986","unstructured":"Prager G, Cimander K, Wagner W, Schnitker J, Koch HF (1986) The cardiotropic effect of antidepressants. A comparison with fluvoxamine. Adv Pharmacotherapy 2:133\u2013150","journal-title":"Adv Pharmacotherapy"},{"key":"BF02191808_CR24","first-page":"548","volume":"5","author":"G Prager","year":"1991","unstructured":"Prager G, Stollmaier W, Prager R, Koch HF, Wagner W, Klein HE (1991) Sicherheit und Vertr\u00e4glichkeit von Fluvoxamin bei kardialen Risikopatienten. TW Neurol Psychiatr 5:548\u2013562","journal-title":"TW Neurol Psychiatr"},{"key":"BF02191808_CR25","first-page":"281","volume":"25","author":"SH Preskorn","year":"1989","unstructured":"Preskorn SH, Jerkovich GS, Beber JH, Widener P (1989) Therapeutic drug monitoring of tricyclic antidepressants: a standard of care issue. Psychopharmacol Bull 25:281\u2013284","journal-title":"Psychopharmacol Bull"},{"key":"BF02191808_CR26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/bmj.2.6182.102","volume":"2","author":"EA Raeder","year":"1979","unstructured":"Raeder EA, Zinsli M, Burckhardt D (1979) Effect of maprotiline on cardiac arrhythmias. Br Med J 2:102\u2013103","journal-title":"Br Med J"},{"key":"BF02191808_CR27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2125.1982.tb02040.x","volume":"14","author":"JF Robinson","year":"1982","unstructured":"Robinson JF, Doogan DP (1982) A placebo controlled study of the cardiovascular effects of fluvoxamine and clovoxamine in human volunteers. Br J Clin Pharmacol 14:805\u2013808","journal-title":"Br J Clin Pharmacol"},{"key":"BF02191808_CR28","doi-asserted-by":"crossref","first-page":"439S","DOI":"10.1111\/j.1365-2125.1983.tb02135.x","volume":"15","author":"JC Roos","year":"1983","unstructured":"Roos JC (1983) Cardiac effects of antidepressant drugs. A comparison of the tricyclic antidepressants and fluvoxamine. Br J Clin Pharmacol 15:439S-445S","journal-title":"Br J Clin Pharmacol"},{"key":"BF02191808_CR29","doi-asserted-by":"crossref","unstructured":"Roos JC (1984) Cardiac effects of antidepressant drugs. A comparison of the tricyclic antidepressants and fluvoxamine. In: Duphar Medical Publications (ed) Proceedings of the International Symposium on Fluvoxamine, Amsterdam 8\u20139 September 1983, Bern, pp 25\u201330","DOI":"10.1111\/j.1365-2125.1983.tb02135.x"},{"issue":"Suppl","key":"BF02191808_CR30","first-page":"34","volume":"52","author":"SP Roose","year":"1991","unstructured":"Roose SP, Dalack GW, Woodring S (1991) Death, depression, and heart disease. J Clin Psychiatry 52: 6(Suppl) 34\u201339","journal-title":"J Clin Psychiatry"},{"issue":"Suppl","key":"BF02191808_CR31","first-page":"25","volume":"53","author":"SP Roose","year":"1992","unstructured":"Roose SP, Dalack GW (1992) Treating the depressed patient with cardiovascular problems. J Clin Psychiatry 53: 9 (Suppl) 25\u201331","journal-title":"J Clin Psychiatry"},{"key":"BF02191808_CR32","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1176\/ajp.137.8.984","volume":"137","author":"MV Rudorfer","year":"1980","unstructured":"Rudorfer MV, Young RC (1980) Desipramine: cardiovascular effects and plasma levels. Am J Psychiatry 137:984\u2013989","journal-title":"Am J Psychiatry"},{"key":"BF02191808_CR33","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00004714-198812000-00004","volume":"8","author":"LS Schneider","year":"1988","unstructured":"Schneider LS, Cooper TB, Severson JA, Zemplenyi T, Sloane RB (1988) Electrocardiographic changes with nortriptyline and 10-hydroxynortriptyline in elderly depressed outpatients. J Clin Psychopharmacol 8:402\u2013408","journal-title":"J Clin Psychopharmacol"},{"key":"BF02191808_CR34","first-page":"57","volume":"1","author":"RC Smith","year":"1980","unstructured":"Smith RC, Chojnacki M, Hu R, Mann E (1980) Cardiovascular effects of therapeutic doses of tricyclic antidepressants: importance of blood level monitoring. J Clin Psychiatry 1:57\u201363","journal-title":"J Clin Psychiatry"},{"key":"BF02191808_CR35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00004714-199104000-00004","volume":"11","author":"SL Stern","year":"1991","unstructured":"Stern SL, Ribner HS, Cooper TB, Nelson LD, Johnson MH, Suckow RF (1991) 2-Hydroxydesipramine and desipramine plasma levels and electrocardiographic effects in depressed younger adults. J Clin Psychopharmacol 11:93\u201398","journal-title":"J Clin Psychopharmacol"},{"key":"BF02191808_CR36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/archpsyc.1994.03950050071008","volume":"51","author":"RC Veith","year":"1994","unstructured":"Veith RC, Lewis N, Linares OA, Barnes RF, Raskind MA, Villacres EC, Murburg MM, Ashleigh A, Castillo S, Peskind ER, Pascualy M, Halter JB (1994) Sympathetic nervous system activity in major depression. Arch Gen Psychiatry 51:411\u2013422","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl","key":"BF02191808_CR37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-2007-1014371","volume":"26","author":"W Wagner","year":"1993","unstructured":"Wagner W, Plekkenpol B, Gray TE, Vlaskamp H, Essers H (1993) Safety database on fluvoxamine: analysis and report. Pharmacopsychiatry 26(Suppl):10\u201316","journal-title":"Pharmacopsychiatry"},{"key":"BF02191808_CR38","doi-asserted-by":"crossref","unstructured":"Warrington SJ, Padgham C, Lader M (1989) The cardiovascular effects of antidepressants. Psychol Med (Suppl): 16","DOI":"10.1017\/S0264180100000709"},{"key":"BF02191808_CR39","first-page":"197","volume":"263","author":"W Wouters","year":"1983","unstructured":"Wouters W, Deimann W (1983) Acute cardiac effects of fluvoxamine and other antidepressants in conscious rabbits. Arch Int Pharmacodyn Ther 263:197\u2013207","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"BF02191808_CR40","first-page":"83","volume":"23","author":"JH Wright","year":"1978","unstructured":"Wright JH, Denber HCB (1978) Clinical trial of fluvoxamine. A new serotonergic antidepressant. Curr Ther Res 23:83\u201389","journal-title":"Curr Ther Res"},{"key":"BF02191808_CR41","first-page":"1709","volume":"30","author":"G Zbinden","year":"1980","unstructured":"Zbinden G, Ettlin R, Bachmann E (1980) Electrocardiographic changes in rats during chronic treatment with antidepressant and neuroleptic drugs. Arzneimittelforschung 30:1709\u20131725","journal-title":"Arzneimittelforschung"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02191808.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02191808\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02191808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T05:06:45Z","timestamp":1706591205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02191808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,12]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,12]]}},"alternative-id":["BF02191808"],"URL":"https:\/\/doi.org\/10.1007\/bf02191808","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,12]]}}}